
Home » ENCYSIVE SUBMITS THELIN RESPONSE TO FDA
ENCYSIVE SUBMITS THELIN RESPONSE TO FDA
May 25, 2006
Shares of Encysive Pharmaceuticals Inc. soared in early trading on Thursday as the pharmaceutical company said it submitted a complete response to the U.S. Food and Drug Administration regarding the company's new drug application for Thelin.
The
Houston Chronicle
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
10Mar
-
16Mar
-
18Mar
-
23Mar
-
30Mar
-
06Apr